AstraZeneca

AZD1222, given as a half dose, followed by a full dose at least one month apart, showed vaccine efficacy of 90 per cent while it…

The prophylactic treatment may prove useful in people whose immune systems are weaker or compromised, and who don’t respond to…

Vaccine developers are selecting manufacturers that are closer to their homes, which could be due to storage or manufacturing…

In rolling reviews, regulators can see clinical data in real-time and have discussions with pharma companies on manufacturing…

62 per cent of patients stopped OCS use completely

Sources say that the trial would have been suspended if the volunteer who died had received the COVID-19 vaccine, suggesting the…

The agreement, under Operation Warp Speed, is to develop a monoclonal antibody cocktail that can prevent COVID-19, especially in…

If it is approved by the regulators, the UK’s NHS is said to be in a position to begin mass vaccination almost immediately

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

The arrangement again provides an option to secure additional doses if the vaccines pillar of the Access to COVID-19 Tools…